共 235 条
[1]
Sartori R(2021)Mechanisms of muscle atrophy and hypertrophy: implications in health and disease Nat Commun 12 330-1174
[2]
Romanello V(2019)Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis J Cachexia Sarcopenia Muscle 10 1165-1074
[3]
Sandri M(2021)The impact of body composition on treatment in ovarian cancer: a current insight Expert Rev Clin Pharmacol 14 1065-546
[4]
Ubachs J(2020)Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer J Cachexia Sarcopenia Muscle 11 534-79
[5]
Ziemons J(2021)Prognostic implications of body composition change during primary treatment in patients with ovarian cancer: a retrospective study using an artificial intelligence-based volumetric technique Gynecol Oncol 162 72-7157
[6]
Minis-Rutten IJG(2022)Quality of life of ovarian cancer patients treated with combined platinum taxane chemotherapy: a systematic review of the literature Support Care Cancer 30 7147-3378
[7]
Kruitwagen R(2022)Assessment of quality of life among advanced ovarian cancer patients in a tertiary care hospital in India Support Care Cancer 30 3371-1301
[8]
Kleijnen J(2022)Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study J Cachexia Sarcopenia Muscle 13 1289-324
[9]
Lambrechts S(2022)Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients J Cachexia Sarcopenia Muscle 13 311-9
[10]
McSharry V(2018)The role of systemic inflammation in cancer-associated muscle wasting and rationale for exercise as a therapeutic intervention JCSM Clin Rep 3 1-E1538